Phase 1 Osteoporosis Clinical Trials
7 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–7 of 7 trials
Completed
Phase 1
A Study to Compare the Pharmacokinetic, Pharmacodynamics, safety, Tolerability and Immunogenicity of BP16 versus Prolia (US and EU approved) in Healthy male Volunteers.
Osteoporosis
CuraTeQ Biologics Private Ltd.204 enrolled3 locationsACTRN12623000520639
Completed
Phase 1
Development of an Oral Preparation of Zoledronic Acid for Use in Postmenopausal Osteoporosis/Osteopenia
OsteoporosisOsteopenia
The University of Auckland30 enrolled1 locationACTRN12621001521819
Not Yet Recruiting
Phase 1
A Study to Compare the Pharmacokinetic Similarity of JHL1266 versus Prolia in Healthy Subjects
Osteoporosis
JHL Biotech Australia Pty Ltd.225 enrolled1 locationACTRN12620000013965
Completed
Phase 1
A double blind single-dose study to evaluate pharmacokinetics, safety and tolerability of Stelis Teriparatide [rh-PTH (1-34)] with innovator product Forsteo Registered Trademark (European Innovator) in healthy volunteers via subcutaneous administration of a single dose of 20 mcg .
Osteoporosis
Stelis Biopharma Pvt. Ltd.24 enrolled1 locationACTRN12615000358549
Not Yet Recruiting
Phase 1
Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RPH-203 Following a Single Dose in Healthy Male Volunteers
Osteoporosis
Nucleus Network Limited48 enrolled1 locationACTRN12613000651785
Terminated
Phase 1
Single-ascending dose of CEP 37251 in Healthy Postmenopausal Women
Osteoporosis in Healthy Postmenopausal Women
Cephalon, Inc.54 enrolled1 locationACTRN12610000379011
Completed
Phase 1
Community-based health organisations and chronic illness care
Access to community-based health organisations amongst patients with chronic illnessHaemochromatosisAsthma+4 more
Dr Fran Boyle, The University of Queensland650 enrolled1 locationACTRN12607000167460